主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Yang Tingting1 Wang Ziyi2 Liu Guangzhi1
单位:1首都医科大学附属北京安贞医院神经内科,北京100029;2北京市普仁医院神经内科,北京100000
英文单位:1Department of Neurology Beijing Anzhen Hospital Capital Medical University Beijing 100029 China; 2Department of Neurology Beijing Puren Hospital Beijing 100000 China
英文关键词:Neuromyelitisopticaspectrumdisorders;Pregnancy;Immunotherapy
视神经脊髓炎谱系疾病(NMOSD)是一种主要由体液免疫介导,以视神经、脊髓和极后区受累为主的中枢神经系统炎性脱髓鞘疾病,具有女性多见、复发频繁、高致残性的特点。因好发于育龄期女性,妊娠期及产后复发风险增加,且控制该病复发的多种免疫抑制剂具有致畸性等不良反应,因而育龄期患者应根据自身病情,做好妊娠计划,选择合适的药物。本文围绕NMOSD患者在计划妊娠、妊娠期、哺乳期间的免疫治疗研究进展进行综述。
Neuromyelitis optica spectrum disorders(NMOSD) is an inflammatory demyelinating disease of central nervous system, which mainly affects the optic nerve, spinal cord and area postrema , mediated by humoral immunity. NMOSD is more common in young female, with frequent recurrence and high disability. Due to mainly occurred in child-bearing period female, increased risk of recurrence during pregnancy and after childbirth, and teratogenicity of immunosuppressive agents to control relapses of NMOSD, female patients should make pregnancy plans and choose appropriate drugs according to their own conditions. This paper provides a review of research progress in immunotherapy for NMOSD patients during planned pregnancy, pregnancy, and lactation.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。